HIV Testing in a High‐Incidence Population: Is Antibody Testing Alone Good Enough? | Zendy

Joanne D. Stekler | Zendy; Paul D. Swenson | Zendy; Robert W. Coombs | Zendy; Joan Dragavon | Zendy; Katherine K. Thomas | Zendy; Catherine A. Brennan | Zendy; Sushil G. Devare | Zendy; Robert Wood | Zendy; Matthew R. Golden | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

HIV Testing in a High‐Incidence Population: Is Antibody Testing Alone Good Enough?

Author(s) -

Joanne D. Stekler,

Paul D. Swenson,

Robert W. Coombs,

Joan Dragavon,

Katherine K. Thomas,

Catherine A. Brennan,

Sushil G. Devare,

Robert Wood,

Matthew R. Golden

Publication year - 2009

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/600043

Subject(s) - medicine , antibody , window period , immunoassay , men who have sex with men , virology , human immunodeficiency virus (hiv) , incidence (geometry) , population , nucleic acid test , immunology , disease , syphilis , serology , infectious disease (medical specialty) , covid-19 , physics , environmental health , optics

The Centers for Disease Control and Prevention recently recommended the expansion of human immunodeficiency virus (HIV) antibody testing. However, antibody tests have longer "window periods" after HIV acquisition than do nucleic acid amplification tests (NAATs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research